ClinicalTrials.gg
CompletedNCT07891143Updated Oct 23, 2026

Effect of High Intensity Aerobic Exercise on Pain Threshold and Blood Pressure in Females With Primary Dysmenorrhea

An interventional study of High Intensity Aerobic Exercise in Primary Dysmenorrhea, sponsored by Lincoln University College. Completed at 1 site in Malaysia. Open to female participants aged 17 Years to 49 Years. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by Lincoln University College · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 1 month after the study started (first participant enrolled Sep 2024, registered Oct 2026).
Updated Oct 23, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
110
Allocation
Randomized
Ages
17 Years to 49 Years
Sex
Female
01

Study summary

Primary dysmenorrhea is common among females of reproductive age and is characterized by painful menstrual cramps without an underlying pelvic disease. This pain can affect daily activities, academic performance, work, and quality of life.

This study aims to investigate the effect of high-intensity aerobic exercise on pain threshold and blood pressure in females with primary dysmenorrhea. The study will assess changes in pain threshold and blood pressure following high-intensity aerobic exercise. The findings may help determine whether this type of exercise can improve pain tolerance and influence blood pressure in females experiencing painful menstrual periods.

Participants will perform a high-intensity aerobic exercise program, and their pain threshold level will be assessed by a digital algometer before and after the exercise intervention and the blood pressure changes will also be studied.

Read the detailed description

Primary dysmenorrhea is a common gynecological condition characterized by recurrent, cramping pain in the lower abdomen during menstruation in the absence of identifiable pelvic pathology. It is associated with increased production of prostaglandins, which leads to excessive uterine contractions, reduced uterine blood flow, and menstrual pain. Primary dysmenorrhea may negatively affect daily activities, academic performance, work productivity, sleep, and overall quality of life.

Exercise has been suggested as a non-pharmacological approach for managing menstrual pain. Aerobic exercise may influence pain perception through the activation of endogenous pain-inhibitory mechanisms, including the release of endogenous opioids and other pain-modulating substances. Exercise may also improve cardiovascular function and autonomic regulation, potentially influencing blood pressure. However, the effects of high-intensity aerobic exercise on pain threshold and blood pressure in females with primary dysmenorrhea require further investigation.

The purpose of this study is to investigate the effect of high-intensity aerobic exercise on pain threshold and blood pressure in females diagnosed with primary dysmenorrhea. The study will evaluate changes in pain threshold and blood pressure following a structured high-intensity aerobic exercise intervention. The exercise protocol followed is at 85% of heart rate given three times a week for 25 minutes /session. This is according to the American heart association guideline for high intensity Aerobic Exercises

Eligible participants will be females of reproductive age with a history of primary dysmenorrhea who meet the predefined inclusion and exclusion criteria. Participants will undergo baseline assessment, including demographic and relevant clinical information, pain threshold measurement, and blood pressure measurement using standardized procedures.

The intervention group will participate in a structured high-intensity aerobic exercise programme according to the study protocol. Maximum heart rate is calculated for each participant using the Karvonen's Formula and then maximum heart rate is calculated for each participant accordingly. The participants are advised to wear comfortable clothing and also wear smart watch. The exercise programme will specify the type of aerobic activity, exercise intensity, duration of each session, frequency of sessions, total intervention period, and warm-up and cool-down procedures. Exercise intensity will be monitored using an appropriate method, such as heart-rate monitoring or the rating of perceived exertion. Rate of perceived exertion scale was used to to guage the exercise effect after the session and was recorded. Participants will be supervised or monitored as specified in the protocol to promote adherence and safety. The exercises consist of jumping jacks, step climber, mountain climber, knee hugs, lunges, partial squats and others. This exercises were selected and validated by five experts from the field of physiotherapy and exercise.

Pain threshold will be assessed using a standardized and reproducible measurement method, such as a pressure pain threshold assessment with an appropriate algometer, if applicable to the study protocol. Blood pressure will be measured using a validated blood pressure monitor under standardized resting conditions. Systolic and diastolic blood pressure will be recorded at the specified assessment time points. Baseline and post-intervention measurements will be compared to determine changes associated with the exercise programme.

The primary outcome will be the change in pain threshold from baseline to post-intervention. The secondary outcome will be the change in systolic and diastolic blood pressure over the same period. Additional outcomes, if included in the study protocol, may include menstrual pain intensity, exercise adherence, and intervention-related adverse events.

The findings of this study may contribute to a better understanding of the effects of high-intensity aerobic exercise on pain sensitivity and cardiovascular responses in females with primary dysmenorrhea. The results may help inform the development of evidence-based exercise recommendations as a potential non-pharmacological approach to managing primary dysmenorrhea.

02

Conditions studied

  • Primary Dysmenorrhea

Browse trials for

Keywords

  • Pain Threshold
  • Primary Dysmennorrhea
  • Blood Pressure
  • High Intensity Aerobic Exercise
03

In context

Dysmenorrhea

430 studies on the registry are indexed under Dysmenorrhea; 107 are open to participants now.

This study's enrollment of 110 is above the median of 62 across 363 interventional studies indexed under Dysmenorrhea.

Browse Dysmenorrhea studies →

Lead sponsor

Lincoln University College is the lead sponsor of 15 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
17 Years to 49 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Females Age 17-49 years
  • History of PD for past 3 months with months (Visual Analogue pain scale more than 5 on day 1 and 2 and consecutive days)
  • Unmarried
  • Nulliparous
  • Normal menstrual cycle - 28-35 days cycle
  • Normal to overweight(18.5-25 kg/m2 is normal)

Exclusion criteria

Exclusion Criteria:

  • Any secondary dysmenorrhea or Gynecologic issue
  • Active in sports
  • Any Cardiorespiratory or musculoskeletal issue
  • History of Hypertension
  • Oral or Analgesic
  • Participants need to undergo Primary Dysmenorrhea Screening conducted by a Gynecologist to get diagnosed with Primary Dysmenorrhea and be further eligible to be a part of the further study.
  • This consist of detailed menstrual history taking and abdominal and pelvis palpation by the Gynecologist doctor.
  • A general health check-up was also included to rule out any hypertension issue.
  • Some important points were considered as well :
  • VAS score: Visual analogue scale VAS score greater than 5 is required on both the first and second days of menstruation
  • Medication use: Define the required medication-free period, if any, and whether occasional analgesic use is permitted.
  • Participants should not be instructed to discontinue prescribed medication without appropriate clinical guidance.
  • Blood pressure safety: Since intervention involves high-intensity aerobic exercise and blood pressure is an outcome, include a suitable pre-exercise screening procedure and safety criteria for elevated blood pressure. Blood pressure was measured in this session as well along with .
  • Medication use: Define the required medication-free period, if any, and whether occasional analgesic use is permitted.
  • Participants should not be instructed to discontinue prescribed medication without appropriate clinical guidance.
  • Active in sports or athletics were not eligible.
  • Blood pressure safety: Since intervention involves high-intensity aerobic exercise and blood pressure is an outcome a suitable pre-exercise screening procedure and safety criteria for elevated blood pressure was included.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
110 participants (actual)

Study arms

  • Experimental
    Experimental Group- 55 participants

    High Intensity Aerobic Exercise given at 85 % of heart rate. 3 times/week /25 minute per session with 5 minutes warm up and 5 minutes cool down.

    Other: High Intensity Aerobic Exercise

  • No intervention
    Control group-55 participants

    No treatment given.Participants instructed to carry on with usual lifestyle and do not begin any new exercise program

Interventions

  • OtherHigh Intensity Aerobic Exercise

    intervention intensity is high and consist of structured exercise program

06

What researchers measure

Primary outcomes

  1. Pain Threshold

    Pain Threshold: Measured using a digital algometer at four muscle sites: trapezius (5 cm from the acromion), biceps (15 cm from the glenoid cavity or 9 cm above the elbow crease), rectus abdominis (4 cm lateral to the umbilicus), and gastrocnemius (midpoint between the popliteal fossa and heel). The 1 cm² probe is pressed vertically at 30 kPa until pain is reported; the device automatically records the threshold in kilograms.

    Time frame: Pretest (menstrual days 1-4), post-test 1 (week 4), and post-test 2 (week 8), during menstrual days 1-4.

  2. Blood Pressure

    It is measured using Omron Digital blood pressure monitor. Both Systolic and Diastolic blood pressure will be measured.

    Time frame: On Pretest- all days of menses (day1-day4) .For Post test 1 (at end of 4th week) , Post test 2(at end of 8th week) during day1-day 4 of menses. Recorded in the left arm three times and average is noted. Measured for experimental and control group.

07

Study locations

1 site
  • Physiotherapy department UTAR sungai Long
    Cheras, Selangor 43000, Malaysia
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — pain scores, blood pressure levels

Supporting information: Study protocol, Informed consent form

Time frame: 5th September 2024- 4th Feb 2026

Access criteria: Principal investigator,supervisor, co- supervisor, statistician and if needed publishing study

Data sharing details ↗ · www.utar.edu.my

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 23, 2026
Show all 1 update
  1. Oct 23, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07891143
Lead sponsor
Lincoln University College
Collaborators
Lincoln University College Malaysia, Universiti Tunku Abdul Rahman
Responsible party
Swapneela Jacob (Research Scholar PhD in Health Science, Lincoln University College) — Principal investigator
First posted
Oct 23, 2026
Start date
Sep 5, 2024
Primary completion
Sep 4, 2025
Completion
Mar 4, 2026
Last update
Oct 23, 2026

Study contacts

Nisha Nambiar, PhD
study director · Lincoln University College
Faridah Mohd Said, PhD
study chair · Lincoln University College

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion